Back to Bruce & Co., Inc.
Q2 2026 13F filing
Updated 27 days ago41 disclosed positions worth $369.5M
Portfolio value
$369.5M
Total holdings
41
New positions
0
Closed positions
0
Increased
4
Decreased
18
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ABBV Abbvie | $30.4M | 121.0K | 8.24% | Trimmed(-1.2%) |
| 2 | A ALL-PB Allstate | $29.1M | 122.5K | 7.89% | Trimmed(-2.4%) |
| 3 | A AER AerCap Holdings | $27M | 185.0K | 7.30% | Added(+0.8%) |
| 4 | N NEE-PS Nextera Energy | $25.8M | 294.3K | 6.99% | Trimmed(-2.0%) |
| 5 | M MRK Merck | $24.5M | 190.8K | 6.64% | Trimmed(-1.0%) |
| 6 | U UHAL-B Uhaul B | $24.1M | 417.0K | 6.51% | Trimmed(-7.7%) |
| 7 | D DUK-PA Duke Energy | $18.3M | 144.8K | 4.96% | Trimmed(-0.7%) |
| 8 | V VICR Vicor | $18.2M | 48.0K | 4.93% | Trimmed(-26.1%) |
| 9 | X XELLL XCEL Energy | $14.7M | 182.5K | 3.97% | Trimmed(-1.1%) |
| 10 | C CMS-PC CMS Energy | $11.7M | 153.0K | 3.17% | Trimmed(-1.9%) |
| 11 | A APP AT & T | $10.7M | 518.0K | 2.90% | Trimmed(-1.0%) |
| 12 | A AAPL Apple | $10.7M | 36.9K | 2.89% | Trimmed(-5.1%) |
| 13 | B BHPLF Beta Bionics | $10.4M | 665.7K | 2.82% | Added(+20.9%) |
| 14 | I IIIN Insteel | $10.4M | 343.4K | 2.81% | Unchanged |
| 15 | A ABT Abbott | $10.2M | 112.3K | 2.76% | Trimmed(-1.3%) |
| 16 | N NEMCL Newmont | $9.3M | 100.0K | 2.53% | Unchanged |
| 17 | A AVA Avista | $8.2M | 200.0K | 2.21% | Trimmed(-0.7%) |
| 18 | A ADM Archer Daniels | $7.6M | 100.0K | 2.07% | Unchanged |
| 19 | B BG Bunge | $7.5M | 70.0K | 2.02% | Unchanged |
| 20 | S SUPN Supernus | $7M | 150.0K | 1.89% | Added(+50.0%) |
| 21 | P PFE Pfizer | $6.5M | 268.2K | 1.75% | Trimmed(-1.4%) |
| 22 | D DAR Darling Ingredients | $5.7M | 105.0K | 1.55% | Trimmed(-0.9%) |
| 23 | K KOD Kodiak Sciences | $5.6M | 145.0K | 1.53% | Unchanged |
| 24 | C CC Chemours | $5.1M | 250.0K | 1.39% | Unchanged |
| 25 | U UHAL-B Uhaul | $4.8M | 72.6K | 1.29% | Trimmed(-1.8%) |
| 26 | L LYB Lyondellbasell | $3.2M | 60.0K | 0.85% | Unchanged |
| 27 | P PR Personalis | $3.1M | 233.0K | 0.84% | Unchanged |
| 28 | F FATE Fate Theraputics | $2.7M | 989.2K | 0.72% | Added(+25.3%) |
| 29 | L LLY Eli Lilly | $2.4M | 2.0K | 0.65% | Unchanged |
| 30 | R RLI RLI | $2.4M | 40.0K | 0.64% | Trimmed(-2.0%) |
| 31 | A APGE Apogee | $2.3M | 50.0K | 0.62% | Unchanged |
| 32 | F FOCL FocalTherics | $2.3M | 438.7K | 0.61% | Unchanged |
| 33 | S SIRI XM Sirius | $1.6M | 55.8K | 0.45% | Unchanged |
| 34 | V VG Venture Global | $1.1M | 100.0K | 0.30% | Unchanged |
| 35 | A ASH Ashland | $988K | 15.0K | 0.27% | Unchanged |
| 36 | V VTRS Viatris | $916K | 57.7K | 0.25% | Trimmed(-1.0%) |
| 37 | M MNKD Mannkind | $831K | 195.1K | 0.22% | Unchanged |
| 38 | B BHC Bausch Health | $611K | 124.0K | 0.17% | Unchanged |
| 39 | M MASS 908 Devices | $594K | 68.3K | 0.16% | Unchanged |
| 40 | W WEC WEC Energy | $461K | 3.9K | 0.12% | Unchanged |
| 41 | ? N/A Caribou Biosciences | $440K | 250.0K | 0.12% | Unchanged |